Canopy Growth Corporation (CGC) vs Evolus, Inc. (EOLS)
Canopy Growth Corporation and Evolus, Inc. are both Drug Manufacturers Specialty & Generic companies. Evolus, Inc. is the larger, with a market value of $519.2M against $397.7M — 1.3× the size. Evolus, Inc. grew revenue faster over the last twelve months: 13.9% against 7.80%. Evolus, Inc. has the higher net margin (−10.9% vs −80.4%) and the higher return on invested capital (−14.5% vs −17.2%). Across the 17 metrics below, Evolus, Inc. leads on 14 and Canopy Growth Corporation on 3.
Valuation
Profitability
| Metric | CGC | EOLS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 25.16% | 66.74% | 53.94% |
| Operating margin | (54.89%) | (5.90%) | 0.00% |
| Net margin | (80.39%) | (10.85%) | 0.00% |
| Free cash flow margin | (28.34%) | (6.92%) | 0.00% |
| Return on equity | (40.14%) | 138.57% | (0.40%) |
| Return on assets | (23.54%) | (14.40%) | (3.32%) |
| Return on invested capital | (17.19%) | (14.47%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack